Submissions from 2017
Comprehensive Genomic Profiling of Esthesioneuroblastoma Reveals Additional Treatment Options, Yazmin Odia
Full Text Restricted – Available from BHSF IP or login only
BRAF-V600E mutant papillary craniopharyngioma dramatically responds to combination BRAF and MEK inhibitors, Ashley Roque and Yazmin Odia
Full Text Restricted – Available from BHSF IP or login only
Submissions from 2016
Widely metastatic atypical pituitary adenoma with mTOR pathway STK11(F298L) mutation treated with everolimus therapy, Yazmin Odia
Full Text Restricted – Available from BHSF IP or login only